• Simulated case-control cerebral blood flow imaging data were generated from arterial spin labelling data in a cohort of older adults.
Introduction
Sensitivity analysis is an important aspect of any study design and particularly relevant to Arterial Spin Labelling (ASL) perfusion magnetic resonance imaging (MRI) where the signal-to-noise ratio can be low. ASL is commonly used to measure cerebral blood flow (CBF) at a voxel-wise level and can be analysed in terms of single participants or across a group. CBF images are obtained by magnetically labelling water in blood, a non-invasive approach that is well suited to probe a myriad of neurological conditions (Detre and Alsop, 1999; Théberge, 2008) . In light of the growing interest in using ASL to measure perfusion in clinical and research settings, recent work has focused on the reproducibility and sensitivity of the perfusion estimates (Huettel and McCarthy, 2001; Parkes et al., 2004; Petersen et al., 2010) . One consideration that has received relatively limited attention is the choice of sample size that is required to detect a perfusion effect of interest.
In a recent study, a Monte Carlo simulation was used to model a 10% perfusion difference between two groups and considering a single voxel in the brain (Aslan and Lu, 2010) . By normalising CBF values, the authors show that an 80% true-positive detection rate can be achieved with 20 participants per group. Another sample size study used an ROI analysis to show that between 20 and 40 subjects are required per group to detect a moderate 15% perfusion difference (Murphy et al., 2011) .
In the current study we report a more generalised voxel-wise approach for scenarios in which ROIs are not known a priori, consequently requiring an analysis approach that accounts for the multiple comparison correction. One voxel-wise approach that is appropriate for parametric or non-parametric data is permutation testing (Nichols and Holmes, 2002) . Permutation testing has proven to be effective in diffusion tensor imaging (Nichols and Holmes, 2002; Karlsgodt et al., 2008; Weaver et al., 2009; Cullen et al., 2010) , voxel based morphometry (Thomas et al., 2009) , ASL (MacIntosh et al., 2010; MacIntosh et al., 2008) and BOLD neuroimaging studies (Arichi et al., 2010; Beissner et al., 2011; Jolles et al., 2011) . The permutation approach allows for the estimation of the null distribution and thereby empirically corrects for family wise error associated with multiple comparisons (Nichols and Holmes, 2002) . Another conventionally used voxel-wise approach is to use statistical parametric mapping (SPM) within a General Linear Model (GLM) framework. In the case of SPM, multiple comparison correction can be performed by Gaussian Random Field (GRF) theory and by using both the Z-statistic maximum height threshold for contiguous voxel clusters as well as the cluster probability threshold to identify significant brain regions (Woolrich et al., 2009; Woolrich et al., 2004) .
Given the increased number of ASL studies that perform wholebrain voxel-wise analyses in both case-control (Alsop et al., 2000; Asllani et al., 2009; Fernández-Seara et al., 2012a; Yoshiura et al., 2009 ) and repeated measure designs (Borogovac et al., 2010; Chao et al., 2010; Kim et al., 2006) , it is important to consider the performance of analysis approaches that are used to detect voxel-wise perfusion changes. The current study involves a characterisation of the minimum number of participants that are required to detect a particular percent hypoperfusion (PHP) effect in a case-control design. Simulated perfusion data are generated based on an ASL dataset of elderly adults with ischemic small vessel disease pathology, from which it is possible to estimate clinically realistic inter and intra-subject variability. The hypoperfusion scenarios are restricted to grey matter voxels consistently estimated across the empirical ASL dataset and a comparison of two common voxel-wise analysis algorithms is performed. 
Materials and methods

Participants
The study was conducted with approval from the Sunnybrook Research Institute Research Ethics Board. Twenty-five older adults (mean age 74 ± 8; 13 men, 12 women) were recruited from a neurology memory clinic at Sunnybrook hospital to a study on cerebrovascular disease. Informed consent was obtained from all participants. Individuals reported subjective cognitive complaints and had a history of a cerebrovascular event or a neurodegenerative profile. Participants had pre-existing risk factors such as a history of transient ischemic attack or moderate amounts of white matter disease ascertained from structural MRI. The breakdown of these demographics, including cardiovascular comorbidities, are provided in Table 1 .
MRI acquisition
ASL perfusion images were acquired on a 3 Tesla Philips Achieva MRI system using body coil transmission and an 8-channel receiver head coil. Pseudo-continuous arterial spin labelling (pcASL) images were acquired with echo planar imaging (EPI) (TR/TE = 4000/9.7 ms, FOV 19 × 19 × 9 cm 3 , 64 × 64 × 18 matrix, voxel dimensions 3 × 3 × 5 mm 3 , 1650 ms labelling duration, postlabel delay = 1600 ms, 35 control and tag pairs, scan duration 4:48 min) (Van Osch et al., 2009 ). The label was prescribed 80 mm below the lowest pcASL slice, perpendicular to the internal carotid arteries and typically between C1 and C2 cervical vertebrae.
Pre/post-processing
Control and tag images were separated from the ASL dataset and MCFLIRT was used to align the time series of images. After registering the mean control and tag images to a common reference space using FLIRT (Jenkinson et al., 2002) with seven degrees of freedom, the mean tag image was subtracted from the mean control image to produce a CBF-weighted difference image. Each participant's CBF image was divided by a proton density weighted image (TR = 10 s, TE = 10 ms), as per current recommended guidelines (Alsop et al., 2014) . CBF images were subsequently intensity normalised and then aligned using MCFLIRT with six degrees of freedom to the group mean image, which served as the group template. All processing was performed using FMRIB Software Library (FSL). (global mean = 45 ml/100 mg/min, SD = 13 ml/100 mg/min), averaged from the 25 subject CBF images following coregistration in FSL. The simulated ROI is superimposed in the occipital-parietal cortex, comprised of 70 contiguous voxels. Bottom (right): Standard deviation template across the group (CBF ) as generated in FSL, expressed as a percentage of the average global CBF value (global mean SD = 33%).
Simulation of CBF images
Empirical data were used to generate a group mean CBF (CBF ) and a group standard deviation (SD, CBF ) image (Fig. 1) . Global, grey matter and white matter perfusion mean signal in the empirical group mean template were 26 (SD 8), 31 (SD 6), and 22 (SD 8) ml/100 mg/min, respectively. CBF was scaled to a global level of 45 ml/100 mg/min, which was based on an expected grey matter CBF level for older adults (Last, 2007) and is consistent with other clinical reports of similar clinical elderly populations with Alzheimer's Disease or Parkinson's Disease and Dementia diagnoses (Last, 2007; Chen et al., 2012; Le Heron et al., 2014; Fernández-Seara et al., 2012b; Alexopoulos et al., 2012; Melzer et al., 2011) . Both CBF and CBF were used to set the parameters for the following simulation approach.
Simulation of a case group included the addition of global signal variation at the voxel level prior to imposing a regional hypoperfusion, as reflected in the Supplementary Figure process diagram. For a given case subject, this global voxel-wise variability was simulated by assuming that every voxel value comes from a normal distribution of specified by the value of CBF at that voxel and a specified by the value of CBF at the same voxel. Thus every ith voxel value was imposed independently by generating a random number from a normal distribution N(CBF(i), CBF(i)). A Shapiro-Wilk test was performed on every voxel in the masked CBF image (22,077 voxels) to test the distribution across the 25 empirical subjects. 14.9% of voxels deviated from a group 2-tailed Gaussian distribution at p > 0.05 (13.5% in grey matter, 10.3% in white matter).
Following the addition of global voxel variability, the values within a 70-contiguous-voxel (3.15 ml) parietal-occipital ROI (Fig. 1B ) were reassigned to model an imposed hypo-perfusion scenario (corresponding to the second last procedural step as seen in the Supplementary Figure) . The mean CBF in the ROI was reduced by 5-20% in increments of 2-3%, and from 20% down to 30%, 40%, and 50% in increments of 10%. Thus ten hypoperfusion scenarios were generated for the simulations. Within-ROI variability was modeled by setting spatial standard deviation to be 0.05, 0.15, and 0.40 times the imposed ROI mean, which is consistent with standard deviations observed across grey matter (Petersen et al., 2010; . The hypoperfusion scenarios were designed to sample a larger proportion of low to modest cases and fewer cases of dramatic hypoperfusion (i.e., >40% decrease in perfusion). Inter-subject variability in the degree of percent hypoperfusion imposed in the case group was kept low (at most 2.2%) to model the scenario in which the case group has a relatively consistent hypoperfusion syndrome.
Simulation of control subjects involved a single step, as reflected above, which was the addition of global voxel-wise variability. In this manner the mean CBF in the ROI region of control subjects reflected that of the empirical CBF (51 ml/100 mg/min) and the resulting inter-subject variability in this value was at most 4.7% due to the addition of global voxel-wise variability. The ROI percent hypoperfusion scenarios imposed in the case group were thus relative to the empirical CBF value of the same ROI in controls. A 2 mm FWHM Gaussian smoothing kernel was applied on both case and control CBF datasets in order to introduce spatial autocorrelation. The Gaussian smoothing had the effect of diffusing the strictly imposed hypoperfusion values above to generate a distribution of hypoperfusion scenarios.
Varying global voxel-wise variability levels in both control and case subjects were simulated by varying the multiple of CBF (i) (used in the first step to indicate the sigma value of the normal distribution from which voxel values were extracted) from 1 to 2 in increments of 0.125 (total of 9 noise levels). Upper case hypoperfusion scenarios of 40% and 50% were sampled less densely with only three increments of 1, 1.5, and 2.
The smallest sample size that was considered was N = 8 per group (i.e., eight patients, eight controls). Sample size was incremented by four until the largest sample size of 72 per group, while keeping the number of participants equal between groups, resulting in a total of 17 different sample sizes. The largest hypoperfusion scenarios of 40 and 50 were sampled less densely with largest sample size of 36 per group, resulting in a total of eight different sample sizes.
Overall, for the eight moderate hypoperfusion scenarios at nine global voxel-wise variability levels, at three levels of ROI voxelwise variability there is a total of 216 case-control scenarios. Each scenario was tested at 17 different sample sizes, giving 3672 total scenarios. Additionally, the two upper case perfusion cases at three global voxel-wise variability levels and at three levels of ROI voxel-wise variation add an additional 18 case-control scenarios, each at eight different samples size (144 upper case-control scenarios). This work therefore examines a total of 3816 simulated case-control scenarios. Representative simulated case and control images following Gaussian kernel smoothing are shown in Fig. 2. 
Voxel-wise statistical analysis
To compare the results of the two different algorithms, the 3816 simulated case-control scenarios were run separately in a voxelwise whole-brain unpaired analysis using two algorithms that are part of the FMRIB software library (FSL Version 4). Algorithms were run in a Linux environment (Ubuntu 11.04). The permutation testing algorithm, called Randomise, involved 5000 permutations and a Threshold Free Cluster Enhancement (TFCE) to correct for multiple comparisons with default cluster parameters of H = 2 (power of the cluster height), E = 0.5 (power of cluster extent), and C = 6 (degree of connectivity) (Smith and Nichols, 2009 ). Voxels with corrected p-value <0.05 were considered significant. The second group analysis method was an SPM approach known as FLAME (FMRIB's Local Analysis of Mixed Effects), run within the fMRI Expert Analysis Tool (FEAT). The SPM analysis was carried out in the conventional manner without the inclusion of voxelwise estimates of variance from the subject level data. Cluster thresholding with cluster Zscore > 1.96 and cluster significance threshold of p-value < 0.05 was applied to correct for multiple comparisons.
Evaluation
The percentage of voxels within the case ROI that were detected as being significantly different from controls was termed the true positive rate (TPR). For each simulated scenario, the ROI was detected as significant if 35 out of the 70 ROI voxels were below the corrected p-value threshold of p = 0.05. A tolerance of one voxel was permitted for this TPR threshold of 50%, i.e., 50 ± 2%, to account for round off error on the corrected p-value estimates. The TPR was used to generate power curves and compare across sample size (N), PHP in the ROI, and choice of algorithm. The false positive rate (FPR), defined here as the percentage of voxels outside the ROI classified as significant after multiple comparison correction, was also monitored. From the power curves, the minimum N required for 50% TPR was extracted and plotted against the PHP for every simulated scenario. To model the dependence of the minimum N on the PHP, curve fitting was performed with a non-linear regression model using iterative least squares estimation in MATLAB. Two exponential curves were applied with three parameters to estimate: N = A 1 exp(−A 2 × PHP) + A 3 (Model A) and N = B 1 exp(−B 2 × PHP 2 ) + B 3 (Model B). Models were compared to a linear fit. An F-statistic was used to compare the ratio of the residual sum of squares to the parameter gain between the simpler linear model and the more complex Model A or B. The post-fitting coefficient covariance matrix and the residuals were used to determine 95% confidence intervals on the fitted coefficients.
Results
Simulated group characteristics
The global, grey matter, and white matter values in the final simulated images and their corresponding ranges of spatial variability across subjects were 44 (14-17), 52 (14-17), and 37(14-17) ml/100 mg/min. These values are within range of what is commonly reported for similar elderly populations (Last, 2007; Chen et al., 2012; Le Heron et al., 2014; Fernández-Seara et al., 2012b; Alexopoulos et al., 2012; Melzer et al., 2011) . Out of the 234 simulated hypoperfusion scenarios, 38 did not achieve the 50% (±2%) TPR threshold criterion in the range of the 17 sample sizes considered. Thirty-three of these 38 produced non-significant findings in both FEAT and Randomise and corresponded to scenarios where the perfusion difference between case and control groups was relatively small. The average PHP of the case group in these 33 scenarios was 4.2 (SD 2.7), while the variability within the ROI was 25% (SD Characteristics of the 196 simulated scenarios that produced a significant group perfusion difference. The mean CBF value in each subject's ROI was computed and the inter-subject standard deviation of the ROI means across a group of N subjects was recorded. The distribution of values within the ROI was recorded as the ROI voxel-wise variability and presented as the percent standard deviation of the ROI mean. PHP is the percent hypoperfusion in the mean ROI CBF in the case group relative to the control, in percent units. The table presents the median, standard deviation (SD), and range across the entire simulated 196 case-control scenario database. All values are in percent units. Fig. 3 . Distribution of the percent ROI hypoperfusion value across the 196 simulated scenarios, characterised by minimum = 1.6%, maximum = 42%, mean = 15%, and median = 13%. The number of simulated scenarios in each bin (left to right): 48, 65, 41, 24, 9, and 9.
3) of the mean in controls and 15% (SD 3) in cases. The additional 5 out of 38 scenarios did not achieve 50% TPR for Randomise only. The PHP of the case group in these 5 scenarios was on average 5 (SD 4), while variability within the ROI was 29% (SD 3) of the mean in controls and 18% (SD 3) in cases. The combination of low PHP in the case group and high voxel-wise variability within the ROI was likely to reduce the sensitivity in detecting the imposed regional perfusion difference. The remaining 196 scenarios produced a significant outcome (>50 ± 2% TPR) in at least 1 of the 17 sample sizes and are thus considered in more detail herein. The distribution of these 196 casecontrol scenarios is presented in Fig. 3 , in terms of the PHP across the case group, with additional characteristics specified in Table 2 . Note that the low inter-subject standard deviation in the ROI means (medians of 4.9% in controls, 1.9% in cases) was an attempt to model a "best-case scenario" of a fairly homogenous group sample.
TPR vs. FPR curves
Following analysis the values of TPR and FPR were computed from each of the 3816 case-control scenarios and plotted against one another in Fig. 4 . For the purpose of Fig. 4 , the entire 234 scenario data-set is considered. The distinction between "lowmedium" and "high" sample sizes show an overall shift to higher TPR when higher sample size was used. FPR also increases with PHP but remains remarkably low, well below 1% for both FEAT and Randomise. Compared to Randomise, FEAT demonstrates larger variability in the curve pattern with higher TPRs overall but also higher FPR data points.
Dependence on sample size
For the 196 simulated scenarios, the minimum N required to reach 50% sensitivity is plotted as a function of PHP for both algorithms separately (Fig. 5) . The same data were also binned by PHP (Fig. 5C ) to contrast the algorithm requirements on sample size. Based on the average across each PHP range, 50% (±2%) sensitivity is reached for PHP in the ranges of 1. 6-8.3, 8.3-15, 15-22, 22-28, 28-35, and 35-42 at N of 59, 32, 17, 11, 9 , and 8 per group when Randomise was used, while the comparative N requirements for FEAT when used on the same dataset are significantly lower (Table 3) . For each PHP range, a non-parametric Wilcoxon rank sum test was done on the N requirements of Randomise and FEAT. The statistic was based on the number of simulated scenarios in each PHP range. The resulting p-values indicated significantly higher N requirements to achieve 50% (±2%) sensitivity in Randomise for PHP <25% (Fig. 5C ). There is no difference between the algorithms for PHP >25%. Both algorithms produced minimum simulated sample size requirement of N = 8 when PHP >42%.
A test was done for a linear regression effect of ROI hypoperfusion on sample size. The linear model was significant (p < 0.0001) (for FEAT and Randomise, respectively: adjusted R 2 = 0.38, 0.58, PHP regression t-stat = −16.3, −10.6, for 194 degrees of freedom). ROI spatial variability and the global voxel-wise variability were subsequently included in the regression and were significant predictors of sample size (p < 0.01) For Randomise the statistics were t = 2.80, p = 0.006 and t = 2.6, p = 0.01 for ROI and global variability, respectively, while for FEAT only ROI variability was significant (t = 3.3, p = 0.001) whereas global variability was not (p = 0.38). The three variable regression achieved R 2 = 0.41, 0.61 for FEAT and Randomise, respectively. As ROI hypoperfusion was the primary predictor of sample size, it was further included in the non-linear regression models (Models A and B described above). Both Model A and B were significant (p < 0.0001) and improved model fits in both algorithms, FEAT (R 2 = 0.67 (A), R 2 = 0.71 (B)) and Randomise (R 2 = 0.79 (A), R 2 = 0.81 (B)).
The results of the non-linear regression analysis are shown in Table 4 . The F-statistic showed both Model A and B achieved a more significant fit (p-value < 0.00001) when compared to the linear model (p-value < 0.00001), yet differences between Model A and B were not significant (p-value > 0.3). From the non-linear curves it is estimated that a minimum of 37 and 20 subjects per group are required to detect a 10% PHP using Randomise and FEAT, respectively (Table 5) .
Discussion
The current work presents a novel simulation approach to test the sensitivity of two commonly used algorithms that are designed to detect perfusion differences at a voxel-wise level after correcting for multiple comparisons. First, we observed a consistent exponential drop-off in the minimum sample size 5 . The cohort size that is required to achieve 50% sensitivity in the simulated ROI is plotted as a function of the degree of hypoperfusion for Randomise (A) and FEAT (B). The data are binned with mean percent hypoperfusion per bin indicated on the x-axis (C), where asterisks indicate p-values generated from non-parametric Wilcoxon rank sum test on the two algorithms; <0.0000001 ( * ), <0.0001 ( ** ), >0.1 ( *** ). Data for Fig. 5C is recorded in Table 2 . Supplementary Figure: The diagram supplements the methods described in Section 2.4 and presents the steps taken to simulate the Case and Control images from the empirical templates. required to detect a perfusion difference between the groups as the PHP in the case group increased. Second, there were significant differences between the group analysis algorithms. At low PHP's, Randomise required ∼1.6 times larger sample sizes compared to FEAT. This discrepancy held for moderate PHP's, but the algorithms were equally adept at detecting PHP's >25%. Third, Randomise provided fewer false positives compared to FEAT. Note: N subjects per group (SD) required in an unpaired "case-control" design for 50% sensitivity compared between two algorithms. The N value is an average based on the number of simulated scenarios falling within each range of ROI percent hypoperfusion (a total of 196 across all bins). See bar graph Fig. 5C . Note: Minimum N for 50% TPR at low to moderate PHP case-control difference, estimated by Models A and B.
The TPR vs. FPR curves showed a positive association between TPR and the degree of hypoperfusion. Remarkably, the number of false positives was less than 0.5% for both algorithms, which is a testimony to the rigorous methodology that was used and the applied multiple-comparison correction in both algorithms. We note that the choice of normally-distributed noise in the simulations without a representation of commonly-encountered data spikes may have influenced the observed low false positive rate, meaning the results here may be optimistic relative to an empirical perfusion group analysis. Nevertheless, the data represented in the TPR data (Fig. 4) demonstrate a far higher FPR in FEAT, as much as six times that of Randomise, under equivalent circumstances. This could be interpreted as the baseline FPR detection inherent in each algorithm and could suggest the multiple-comparison correction method employed by the permutation-approach in Randomise is more effective than the cluster-based correction used in FLAME. The positive correlation between sample size and FPR is likely due to the increased chance of false positive detection with a greater pool of Gaussian distributed noise in the image.
The dependence of the sample size required to detect 50% of the ROI on the degree of ROI hypoperfusion is shown to be significantly better approximated by both forms of the proposed exponential models when compared to a linear fit (p-value < 0.00001). As seen in Table 5 , the two models generate very similar numbers. According to the fitted models, a minimum of 37 and 20 subjects will be required per group for detecting a moderate 10% hypoperfusion in a case-control design using Randomise and FEAT, respectively (Table 5 ). The results from the current study suggest that ASL perfusion case-control studies with sample sizes of 10-20 subjects per group may lack sufficient power to detect low or modest regional hypoperfusion effects at a voxel-wise level that are independent of other covarying effects such as atrophy. In cases where a parametric distribution of the data cannot be assumed and therefore using FEAT is not appropriate (since it assumes normality), higher sample sizes should be considered if Randomise is used instead.
Although the simulated range of PHP's was consistent with clinical ASL studies that reported perfusion differences between 8% and 15% (Alsop et al., 2000; Kim et al., 2006; Alexopoulos et al., 2012; Rao et al., 2007) relative to controls (Table 3) , there were a few assumptions in the simulation design that may limit the generalisability of the findings. First, our simulated ROI was situated in the posterior parietal region, near the angular gyrus, a neuroanatomical region that has been reported in multiple perfusion and glucose metabolism studies to be not only associated with Parkinson's Disease and Dementia as well as Mild Cognitive Impairment but also to be predictive of Alzheimer's Disease (Yoshiura et al., 2009; Le Heron et al., 2014; Alexopoulos et al., 2012; Melzer et al., 2011; Kamagata et al., 2011; Landau et al., 2011; Kikuchi et al., 2001; Song et al., 2014) . However future work could further investigate the effect that the ROI size and number of ROIs have on sample size requirements. Second, inter-subject variability within the hypoperfused ROI was designed to be low (1.9%, Table 2), a scenario that would translate clinically to a homogeneous perfusion abnormality among the patient group. Similarly, global perfusion differences or inter-subject variation in the ROI location were not introduced. It is important to note that aside from ROI hypoperfusion, the degree of ROI spatial variability and the global voxel-wise variability were also moderately predictive of sample size (p ≤ 0.01) in the linear regression but were not accounted for in the exponential models because their influence on the model fit were slight in our case. Yet this highlights a need for investigating further the effects that such parameters may have on a region's detectability. We would also like to point out that the data was simulated using a normal distribution even though a small proportion of grey matter voxels in the empirical dataset were found not to be normality distributed. This would have little to no effect on the randomise approach but presumably may impact the GLM approach where a normal distribution is assumed by the algorithm. Third, we assumed spatially uniform noise within subjects (i.e., no CBF intensity spikes due to a poor coregistration or image artifacts, as examples). Fourth, our TPR criteria of 50% meant that there may have been "successful" simulation cases that had 50% false negatives. This criterion was chosen to approximate patient heterogeneity due to differences in anatomy, brain tissue volume or registration issues. Post-hoc we did observe that a TPR criterion of 80% produced greater demands on sample sizes across the PHP range. Future work could address the effect of varying the sensitivity demands depending on the size of ROI that needs to be detected. Lastly, future work on ASL effect sizes could also resample from empirical data directly. This is now feasible given that there are published ASL studies with sample sizes well beyond 100 participants, such as from multi-site studies (Petersen et al., 2010) , clinical exams (Tan et al., 2012) or repositories that are destined to be publicly available (Satterthwaite et al., 2014) .
Despite some limitations, this study adds to the literature on statistical inference in functional neuroimaging and the results were in a range established in previous sample-size estimations (Aslan and Lu, 2010; Murphy et al., 2011; Desmond and Glover, 2002; Murphy and Garavan, 2004) . Sample size requirements determined using FEAT were comparable to previous work on sample-size estimation where BOLD MRI acquisition was used (Desmond and Glover, 2002; Murphy and Garavan, 2004) . For a paired design scenario, Desmond & Glover (Desmond and Glover, 2002) estimate subject variability and percent signal change from a block design fMRI experiment and use these parameters to drive a simulation of subject time series. Assuming a within-subject percent signal change of 0.5% and employing a standard random effects analysis (using a paired ttest), they show that 24 subjects are needed to ensure 80% power for 95% confidence at the single voxel level. A BOLD-based fMRI study for an unpaired design scenario reported that 20 subjects per group could be sufficient for 80% power in reproducing truly activated voxels (Murphy and Garavan, 2004) . A study based on ASL data has reported similar numbers of 20 subjects per group for a moderate 10% group perfusion difference at 80% power (Aslan and Lu, 2010) , or between 20 to 40 subjects per group from an ROI analysis in Murphy et al. (Murphy et al., 2011) . The higher sample size requirement in Randomise as compared to previous sample size studies may be consequence of the stringent permutation approach applied to control for multiple comparisons. The permutation approach requires one less assumption about the data compared to GLM, since a normal distribution is not a requirement for the former but is for the latter. Instead, the null distribution is categorised through the computationally expensive process of testing permutations on the data. Differences between the two approaches may reflect differences in the degree of freedom, with permutations using more degrees of freedom compared to GLM, or false assumptions of normality. The latter reason is one of the main arguments in favour of the permutation approach, as described by others (Nichols and Holmes, 2002; Bullmore et al., 1999) . It remains difficult to compare the numbers reported above with those from previous work directly, as this study is the first to analyze the demands on sample size based on the ability of common algorithmic approaches to detect a regional perfusion change while applying multiple comparison correction.
Conclusion
This study develops the means to estimate the sample size that would be required to detect a particular perfusion abnormality at a voxel-wise level, using commonly implemented algorithms that inherently correct for multiple comparisons. This study is relevant given that there is growing interest in ASL as a non-invasive perfusion MRI technique that can be used for clinical neuroimaging investigations. There is therefore an onus to develop more sophisticated ways to perform group analysis on perfusion images, but also a need to test the effectiveness of specific group analysis approaches in detecting possible perfusion changes.
